Amanote Research
Register
Sign In
Prognostic Importance of the Inflammation-Based Glasgow Prognostic Score in Patients With Gastric Cancer
British Journal of Cancer
- United Kingdom
doi 10.1038/bjc.2012.262
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
June 19, 2012
Authors
X Jiang
N Hiki
S Nunobe
K Kumagai
T Kubota
S Aikou
T Sano
T Yamaguchi
Publisher
Springer Science and Business Media LLC
Related search
The Relationship Between an Inflammation-Based Prognostic Score (Glasgow Prognostic Score) and Changes in Serum Biochemical Variables in Patients With Advanced Lung and Gastrointestinal Cancer
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Significance of the Glasgow Prognostic Score in Predicting the Postoperative Outcome of Patients With Stage III Gastric Cancer
Journal of Clinical Medicine
Evaluation of an Inflammation-Based Prognostic Score (GPS) in Patients With Metastatic Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Comparison of Tumour-Based (Petersen Index) and Inflammation-Based (Glasgow Prognostic Score) Scoring Systems in Patients Undergoing Curative Resection for Colon Cancer
British Journal of Cancer
Cancer Research
Oncology
Assessment of Cachexia in Head and Neck Cancer Patients Based on a Modified Glasgow Prognostic Score
Journal of Otolaryngology of Japan
Otorhinolaryngology
Systemic Inflammation Score Is a Prognostic Marker After Curative Resection in Gastric Cancer
ANZ Journal of Surgery
Medicine
Surgery
Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prealbumin/CRP Based Prognostic Score, a New Tool for Predicting Metastasis in Patients With Inoperable Gastric Cancer
Gastroenterology Research and Practice
Hepatology
Gastroenterology
2379 Prealbumin/CRP Based Prognostic Score, a New Tool for Predicting Metastasis in Patients With Inoperable Gastric Cancer
European Journal of Cancer
Cancer Research
Oncology
